Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon May 08, 2023 7:43pm
60 Views
Post# 35437525

RE:RE:RE:Simple fact

RE:RE:RE:Simple fact boazklinghorn makes the factual assertion, "Gillles has been "quietly" taking 50K a month for over a decade..."

CZO's annual compensation is disclosed every year just as with any other company. There is nothing different about it.

As for boazklinghorn's claim of $50,000 per month for "over a decade" I quickly did a fact check of the disclosure report 10 years ago and total compensation per month was as follows:

2013          $21,516.25    Only 43.03% of $50,000.
2012          $20,304.67    Only 40.60% of $50,000.
2011          $16,308.83    Only 32.62% of $50,000.

With the stock up 497% since Gilles became President & CEO despite being in the worst biotech bear market in history. Key pipeline asset data is also undisclosed as the pipeline is before potential value transforming strategic catalysts. 



"According to the Proph  PGX will finally be ready for commercial applications with 3 or maybe less years of patent left."

If you think those patents are all that is required why wasn't PGX working when the patents were filed? There will be new patents on the way including for New Chemical Complexes. 
<< Previous
Bullboard Posts
Next >>